Your browser doesn't support javascript.
loading
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs.
Austin, Elizabeth J; Gojic, Alexander J; Bhatraju, Elenore P; Pierce, Kathleen A; Pickering, Eleanor I; Tung, Elyse L; Scott, John D; Hansen, Ryan N; Glick, Sara N; Stekler, Joanne D; Connolly, Nancy C; Villafuerte, Sarah; McPadden, Madison; Deutsch, Sarah; Ninburg, Michael; Kubiniec, Robert; Williams, Emily C; Tsui, Judith I.
Afiliação
  • Austin EJ; Department of Health Systems and Population Health, University of Washington, Seattle WA, United States. Electronic address: austie@uw.edu.
  • Gojic AJ; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States.
  • Bhatraju EP; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States.
  • Pierce KA; Department of Pharmacy, University of Washington, Seattle WA, United States; Kelley-Ross Pharmacy Group, Seattle WA, United States.
  • Pickering EI; Department of Social and Behavioral Sciences, Yale School of Public Health, United States.
  • Tung EL; Department of Pharmacy, University of Washington, Seattle WA, United States; Kelley-Ross Pharmacy Group, Seattle WA, United States.
  • Scott JD; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States.
  • Hansen RN; Department of Pharmacy, University of Washington, Seattle WA, United States; Kelley-Ross Pharmacy Group, Seattle WA, United States.
  • Glick SN; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States; HIV/STD Program, Public Health - Seattle & King County, Seattle WA, United States.
  • Stekler JD; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States.
  • Connolly NC; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States.
  • Villafuerte S; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research).
  • McPadden M; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research).
  • Deutsch S; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research).
  • Ninburg M; Hepatitis Education Project, Seattle WA, United States (affiliation at the time of research).
  • Kubiniec R; Evergreen Treatment Services, Seattle WA, United States.
  • Williams EC; Department of Health Systems and Population Health, University of Washington, Seattle WA, United States; Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research & Development, VA Puget Sound, Seattle WA, United States.
  • Tsui JI; Department of Medicine, Division of General Internal Medicine University of Washington, Seattle WA, United States.
Int J Drug Policy ; 111: 103924, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36521197
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Abuso de Substâncias por Via Intravenosa / Hepatite C / Hepatite C Crônica / Usuários de Drogas / Navegação de Pacientes Limite: Humans Idioma: En Ano de publicação: 2023
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Médicos / Abuso de Substâncias por Via Intravenosa / Hepatite C / Hepatite C Crônica / Usuários de Drogas / Navegação de Pacientes Limite: Humans Idioma: En Ano de publicação: 2023